InMed Pharmaceuticals's total assets for Q1 2026 were C$13.36B, an increase of 85657.71% from the previous quarter. INM total liabilities were C$1.77B for the fiscal quarter, a 82418.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.